Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage
Khakoo, S.I., Coles, C.J., Armstrong, J.S. and Barry, R.E. (1995) Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage. Journal of Clinical Gastroenterology, 20, (3), 244-247. (PMID:7797836).
Full text not available from this repository.
3,4-Methylenedioxymetamphetamine ("ecstasy") has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.
|Keywords:||3,4-methylenedioxymetamphetamine, liver, fibrosis, drug reaction, toxicity|
|Subjects:||R Medicine > RC Internal medicine|
|Divisions:||Faculty of Medicine > Infection, Inflammation and Immunity
|Date Deposited:||22 Jun 2012 13:11|
|Last Modified:||27 Mar 2014 20:21|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)